July 20, 2017
Health plans often use different levels of cost sharing to drive patients toward one medication over another. But is this practice fair, ethical or effective in producing positive outcomes for patients? The answer, according to a recent National Pharmaceutical Council webinar panel, all depends.
July 17, 2017
Do coverage decisions aim to offer patients more treatment options – or drive patients to non-identical drugs based on cost alone?
July 11, 2017
It’s been over a year since the launch of former vice president Joe Biden’s Cancer Moonshot, designed to spur innovation and encourage collaboration on finding cures for cancer. So now, patients, physicians, researchers and policymakers are pausing to ask: Are we any closer?
July 6, 2017
Long-awaited treatment for a movement disorder known as tardive dyskinesia could remain out of reach – unless an upcoming cost-effectiveness analysis acknowledges its value to patients.
July 6, 2017
Carl was in and out of the Connecticut prison system for years, struggling to retake control of his life and…
June 29, 2017
Some wore shades, others “showed purple.” But advocates across the board used June’s Migraine & Headache Awareness Month to draw attention to a condition whose patients face debilitating symptoms and far too few treatment options.
June 26, 2017
Health plans across the country are rejecting prescriptions for cholesterol-lowering PCSK9 inhibitors at an average rate of 43 percent. And now one patient advocacy group has a message: Enough is enough.
June 20, 2017
In Massachusetts, some patients with epilepsy must try and fail on their health plans’ preferred prescription medications not once, not twice, but three times before getting the treatment their doctor originally prescribed.
June 14, 2017
Clinical pathways in the age of personalized cancer care may be excluding a key component: patient perspective.
June 12, 2017
GAfPA's workshop drew participants from across Europe who represented a multitude of backgrounds – all linked through their work with pain.
